CBD

CBD
Name	Cannabidiol
Syn	CBD
Drug class	Phytocannabinoid
Routes of administration	Oral; sublingual; inhalation; transdermal; topical; rectal
Legal status	Varies by jurisdiction

CBD

Cannabidiol is a naturally occurring phytocannabinoid derived from species of the Cannabis sativa complex. It is distinct from tetrahydrocannabinol in psychoactivity and is used in clinical, veterinary, and consumer contexts across many regions such as United States, United Kingdom, Germany, Australia, and Canada. Research on cannabidiol intersects with institutions like the World Health Organization, pharmaceutical firms such as GW Pharmaceuticals, regulatory bodies including the Food and Drug Administration, and academic centers like Johns Hopkins University.

Overview

Cannabidiol appears in extracts produced by cultivars developed by breeders associated with Horticulture Research and companies such as Canopy Growth Corporation and Aurora Cannabis. Commercial markets involve retailers like CVS Health, Walgreens Boots Alliance, and specialty brands that emerged after changes in laws such as the Agricultural Improvement Act of 2018. Public discourse has involved policymakers in legislatures like the United States Congress and health advisory bodies like the National Institutes of Health. Historical milestones include clinical approvals by agencies including the European Medicines Agency for specific formulations and pioneering trials at centers such as Massachusetts General Hospital.

Chemistry and Pharmacology

Chemically, cannabidiol is a terpenophenolic compound biosynthesized via pathways studied at institutions like University of California, Davis and King's College London. Analytical profiling techniques developed at laboratories such as those at MIT and Harvard Medical School employ chromatography instruments made by firms like Agilent Technologies and Thermo Fisher Scientific. Pharmacodynamic and pharmacokinetic studies reference receptors characterized in research from National Institute on Drug Abuse and molecular biology groups in Salk Institute. Metabolism studies cite enzymes like cytochrome P450 isoforms investigated at Roche and Pfizer research units. Interactions with ion channels and serotonin receptors were explored in work affiliated with Imperial College London and laboratories collaborating with Novartis.

Medical Uses and Evidence

Approved pharmaceutical formulations were developed by companies including Eli Lilly and GW Pharmaceuticals; one formulation received regulatory approval for seizure disorders following multicenter trials often coordinated by hospitals such as Great Ormond Street Hospital and Mayo Clinic. Clinical trial registries list studies conducted at institutions like UCLA and Stanford University evaluating indications including epilepsy, neuropathic pain, and anxiety. Systematic reviews and meta-analyses published with contributions from researchers affiliated with Cochrane and universities like Oxford assess evidence quality and report variable outcomes. Professional guidelines from societies such as the American Academy of Pediatrics and American Medical Association address use considerations in pediatric and adult populations.

Legal Status and Regulation

Regulatory landscapes differ: agencies like the Food and Drug Administration, the European Medicines Agency, and national authorities in Japan and Brazil apply distinct frameworks. Landmark legislative changes include acts debated in the United States Congress and statutes enacted by bodies like the Parliament of the United Kingdom and the European Parliament. Enforcement and import/export are overseen by customs and drug agencies such as U.S. Customs and Border Protection and the United Nations Office on Drugs and Crime. Industry compliance is shaped by standards organizations including ASTM International and testing laboratories accredited by bodies like ISO.

Safety, Side Effects, and Interactions

Adverse event reporting systems operated by agencies like the Food and Drug Administration and pharmacovigilance units at European Medicines Agency collect data on hepatotoxicity, sedation, and drug interactions. Interaction studies reference concomitant medications from manufacturers such as Johnson & Johnson and antiepileptics examined in trials at Cleveland Clinic. Toxicology assessments are informed by guidance from agencies like the National Toxicology Program and public health advisories issued by ministries such as the Department of Health and Social Care in the United Kingdom.

Products, Formulations, and Production Methods

Commercial products range from prescription medicines developed by firms like GW Pharmaceuticals to consumer formulations marketed by companies such as Charlotte's Web Holdings and Green Thumb Industries. Extraction and purification methods are implemented at industrial facilities using equipment from companies like Centripro and solvent suppliers such as Sigma-Aldrich; methods include supercritical CO2 extraction and ethanol extraction optimized in collaborations involving University of Guelph and private industry. Formulation types include oils, capsules, transdermal patches, and inhalation devices produced by medical device manufacturers including Philips and contract manufacturers regulated under standards from USP.

Research and Controversies

Research agendas are pursued at academic centers like Yale University and biotech startups funded by venture firms on Silicon Valley circuits; controversies have involved patent disputes handled in courts such as the United States Court of Appeals and marketing practices scrutinized by regulators at the Federal Trade Commission. Debates about quality control, labeling, and claims have prompted investigations by media outlets including The New York Times and scientific critiques published in journals associated with Nature Publishing Group and Elsevier. International policy debates have unfolded in forums like the World Health Assembly and multilateral negotiations at United Nations assemblies.

Category:Cannabis